TKTL1-nutrition according to Dr. Coy: Successful treatment in glioblastoma and metastatic colon cancer;TKTL1-ernährung nach Dr. Coy: Therapieerfolge beim glioblastom und metastasierten kolonkarzinom

Deutsche Zeitschrift fur Onkologie

Volumn 39, Issue 4, 2007, Pages 170-174

  Wegener, Beate ^a   Pfisterer, Markus ^b  

^a Medizinische Beratung TAVARLIN   (Germany)

^b NONE   (Germany)

Author keywords

Cancer diet; Colon cancer; Coy diet; Coy principle; Glioblastoma; TKTL1; TKTL1 nutrition; Warburg hypothesis

Indexed keywords

TRANSKETOLASE; TRANSKETOLASE LIKE 1; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER DIET; CANCER INHIBITION; CANCER SURVIVAL; COLON CANCER; COY DIET; DIET; DIET THERAPY; ENZYME INHIBITION; GLIOBLASTOMA; LARYNX CANCER; LUNG CANCER; METASTASIS; OVARY CANCER; TUMOR GROWTH;

EID: 38949110351     PISSN: 16175891     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-986016     Document Type: Article

References (19)

1. Coy JF, Dressler D, Wilde J, Schubert P: Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab. 2005; 51: 257-273.
2. Dimitriu C, Martignoni ME, Bachmann J, Fröhlich B, Tintarescu G, Buliga T, Lica I, Constantinescu G, Beuran M, Friess H: Clinical impact of cachexia on survival and outcome of cancer patients. Rom J Intern Med. 2005; 43 (3-4): 173-185.
3. Gillies RJ, Gatenby RA: Adaptive landscapes and emergent phenotypes: Why do cancers have high glycolysis? J Bioenerg Biomembr. 2007; DOI 10.1007/s10863-007-9085-y.
4. Gottfried E, Kunz-Schughart LA, Ebner S, Mueller-Klieser W, Hoves S, Andreesen R, Mackensen A, Kreutz M: Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood. 2006; 107 (5): 2013-2021.
5. Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, Gottfried E, Sabine Schwarz S, Rothe G, Hoves S, Renner K, Timischl B, Makkensen A, Kunz-Schughart L, Andreesen R, Krause SW, Kreutz M: Inhibitory effect of tumor cell derived lactic acid on human t cells. Blood. 2007; 109 (9): 3812-3819.
6. Kayser G, Kubitz B, Sienel W, Mattern D, Coy J, Passlick B, Werner M, zur Hausen A: Overexpression of transketolase L1 (TKTL1) in primary non small cell lung cancer predicts poor patient outcome and is an important potential therapeutic target. Pathol Res Pract. 2007; 203 (5): 388.
7. Krockenberger M, Honig A , Rieger L, Coy JF, Sutterlin M, Kapp M, Horn E, Dietl J, Kämmerer U: Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Int J Gynecol Cancer. 2007; 17: 101-106.
8. Langbein S, Zerilli M, zur Hausen A, Staiger W, Rensch-Boschert K, Lukan N, Popa1 J, Ternullo MP, Steidler A, Weiss C, Grobholz R, Willeke F, Alken P, Stassi G, Schubert P, Coyl JF: Expression of transketolase TKTL1 predicts colon an urothelial cancer patient survival: Warburg effect reinterpreted. British Journal of Cancer. 2006; 94 (4): 578-585.
9. Otto C, Kämmerer U, Illert B, Mühling B, Thiede A, Coy JF: Metabolic growth control of human TKTL1-positive tumours in nude mice with a ketogenic diet. TumorBiol. 2007; 28 [Suppl 1] S. 18 (S5_A4).
10. Rais B, Comin B, Puigjaner J, Brandes JL, Creppy E, Saboureau D, Ennamany R, Lee WNP, Boras LG, Cascante M: Oxithiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS letters. 1999; 456: 113-118.
11. Sattler UGA, Walenta S, Mueller-Klieser W: Laktat und Redoxstatus in malignen Tumoren. Der Anästhesist. 2007; 5: 38-41.
12. Staiger WI, Coy JF, Grobholz R, Hofheinz RD, Lukan N, Post S, Schwarzbach MH, Willeke F: Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer. Oncol Rep. 2006; 16 (4): 657-661.
13. Stern R, Shuster S, Neudecker BA, Formby B: Lactate Stimulates Fibroblast Expression of Hyaluronan and CD44: The Warburg Effect Revisited. Experimental Cell Research. 2002; 276: 24-31.
14. Völker HU et al: Overexpression of transketolase TKTL1 is associated with shorter survival in laryngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol. DOI 10.1007/s00405-007-0394-x.
15. Walenta S et al: Lactate: Mirror and motor of tumor malignancy. Seminars in Radiation Oncology. 2004; 14: 267-274.
16. Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfør K, Rofstad EK, Mueller-Klieser W: High Lactate Levels Predict Likelihood of Metastases, Tumor Recurrence, and Restricted Patient Survival in Human Cervical Cancers. Cancer Res. 2000; 60: 916-921.
17. Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, Yancy WS, Phinney SD: Low-carbohydrate nutrition and metabolism. The American Journal of Clinical Nutrition. 2007; 86: 276-284.
18. Xu R, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P: Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia. Cancer Res. 2005; 65: (2).
19. Zhou W, Mukherjee P, Kiebish MA, Markis MT, Mantis JG, Seyfried TN: The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutrition & Metabolism. 2007, 4:5 doi:10.1186/1743-7075-4-5.